Comparison of a Demand Oxygen Delivery
Children's Hospital Medical Center, Cincinnati · with National Heart, Lung, and Blood Institute (NHLBI) · NCT06609694
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 5–17 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 10
- US sites recruiting
- 1
- Study start
- January 9, 2023
- Record last updated
- January 7, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Conducting a randomized control trial of oxygen in children with Down syndrome to treat moderate to severe obstructive sleep apnea.
The aim of the study is to conduct a comparison between the 2 methods of oxygen delivery during sleep in 15 children from Cincinnati Children's Hospital and Children's Hospital of Los Angeles. 2 polysomnographies will be performed, one with continuous flow and the second with pulse flow.
Being studied: Portable oxygen concentrator Inogen G5 model
Conditions: Obstructive Apnea
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 5-17 years with or without Down Syndrome (DS).
- Children with obstructive sleep apnea (OSA) and obstructive apnea hypopnea index (OAHI) 5-40 / hour: The rationale for selecting this range of OAHI is that a large number of children with DS with this range of OSA severity are untreated for months to years. It is important to understand the response to oxygen across the spectrum of disease severity. Notably, children with severe disease are left with few options (e.g., tracheostomy).
- Absence of clinically significant hypoxia defined as oxygen saturation \< 88% for 5 minutes or episodic desaturation to 60% as these levels would otherwise identify children eligible to routinely receive oxygen.
Exclusion Criteria
- Current CPAP use with documented compliance (> 4 hrs/ night; > 70% of nights).
- Oxygen saturation \< 90% at rest during wakefulness
- Chronic daytime or nighttime use of supplemental oxygen.
- Unable to participate in a Polysomnogram (PSG).
- Enrolled or planning to enroll in another study that may conflict with protocol requirements or confound results in this trial.
Recruiting US locations
Cincinnati Children's Hospital Medical Center
Cincinnati, OH 45229
Site contact: Suzie Hicks, BS · 5136364944 · suzie.hicks@cchmc.org
Study contacts (from the official record)
- Suzie Hicks, BS · 513-636-4944 · suzie.hicks@cchmc.org
Similar studies in Ohio
All sleep studies in Ohio →- Recruiting
Janus II Feasibility
Zoll Medical Corporation
- Location
- Columbus, OH + 3 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Axsome Therapeutics, Inc.
- Location
- Cincinnati, OH + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.
Incannex Healthcare Ltd
- Location
- Cincinnati, OH + 11 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2/Phase 3
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Alkermes, Inc.
- Location
- Canton, OH + 32 other US sites
- Eligibility basics
- Ages 18–70